Novo Nordisk A/S v. Becton Dickinson and Co.
District Court, S.D. New York
1Opinion of the Court
OPINION and ORDER
JONES, District Judge.
Defendant Becton Dickinson has moved for summary judgment on four issues arguing: (1) that the ’535 patent, ’323 patent, and the ’906 patent are invalid as anticipated under 35 U.S.C. § 102(b) in view of a June 1991 issue of Novo Nordisk’s informational brochure, Medview, containing an article by Lene Lytzen; (2) that all claims of the ’323 patent and claims 11-14 of the ’906 patent are invalid as anticipated under 35 U.S.C. § 102(b) in view of a May 1993 advertising brochure for Novo’s No-voFine G30 pen needle product; (3) that Becton’s G31 insulin pen…
2Cases cited17 opinions
- Warner-Jenkinson Co. v. Hilton Davis Chemical Co.Supreme Court of the United States · 1997
- W.L. Gore & Associates, Inc., Appellant/cross-Appellee v. Garlock, Inc., Appellee/cross-AppellantCourt of Appeals for the Federal Circuit · 1983
- Vas-Cath Incorporated and Gambro, Inc. v. Sakharam D. Mahurkar, and Quinton Instruments CompanyCourt of Appeals for the Federal Circuit · 1991
- Wms Gaming Inc. v. International Game TechnologyCourt of Appeals for the Federal Circuit · 1999
- Continental Can Company Usa, Inc. And Continental Pet Technologies, Inc. v. Monsanto Company, Hoover Universal, Inc. And Johnson Controls, Inc.Court of Appeals for the Federal Circuit · 1991
12 more not listed; retrieve them via the Exa API.
3Cited by9 opinions
- Novo Nordisk A/s, Novo Nordisk of North America, Inc., and Novo Nordisk Pharmaceuticals, Inc. v. Becton Dickinson and Company, Defendant-CrossCourt of Appeals for the Federal Circuit · 2002
- Scanner Technologies Corp. v. Icos Vision Systems Corp.District Court, S.D. New York · 2003
- Finjan, Inc. v. Juniper Networks, Inc.District Court, N.D. California · 2019
- Alza Corp. v. Mylan Laboratories, Inc.District Court, N.D. West Virginia · 2004
- In Re Aventis Pharmaceuticals, Inc.District Court, D. New Jersey · 2005
4 more not listed; retrieve them via the Exa API.